The increasing role of amphiregulin in non-small cell lung cancer.
Busser
B
B
Coll
J-L
JL
Hurbin
A
A
D066258:Amphiregulin; D017209:Apoptosis / Q000502:physiology*; D014408:Biomarkers, Tumor / Q000032:analysis; D002289:Carcinoma, Non-Small-Cell Lung / Q000401:mortality / Q000473:pathology* / Q000503:physiopathology* / Q000628:therapy; D018450:Disease Progression; D066255:EGF Family of Proteins; D066246:ErbB Receptors / Q000502:physiology; D006023:Glycoproteins / Q000502:physiology*; D006801:Humans; D007113:Immunity, Innate; D036341:Intercellular Signaling Peptides and Proteins / Q000502:physiology*; D008175:Lung Neoplasms / Q000401:mortality / Q000473:pathology* / Q000503:physiopathology* / Q000628:therapy; D011379:Prognosis
C587848:AREG protein, human; D066258:Amphiregulin; D014408:Biomarkers, Tumor; D066255:EGF Family of Proteins; D006023:Glycoproteins; D036341:Intercellular Signaling Peptides and Proteins; D066246:ErbB Receptors